InsiderTrades

Form 4 for LH Labcorp

Accepted 2021-09-17 00:00:00 ET · period of report 2021-09-15 · accession 0001127602-21-025442 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-09-17 2021-09-15 LH van der Vaart Sandra D EVP, CLO M - OptEx $84.86 +4,500 9,765 +85% +$381.9K
D 2021-09-17 2021-09-15 LH van der Vaart Sandra D EVP, CLO S - Sale+OE $296.78 -4,500 5,265 -46% -$1.34M
D 2021-09-17 2021-09-15 LH van der Vaart Sandra D EVP, CLO M - OptEx $0.00 -4,500 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-09-15 M A 4,500 $84.86 9,764.78 D — — (F2) Amount includes 27.7429 shares acquired on June 30, 2021 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
2 Common Common Stock 2021-09-15 S D 4,500 $296.78 5,264.78 D — — (F2) Amount includes 27.7429 shares acquired on June 30, 2021 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
3 Derivative Non-qualified Stock Options 2021-09-15 M D 4,500 $0.00 0 D $84.86 · 2013-05-24 to 2022-05-23 4,500 Common Stock (F3) Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan. (F4) The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.